HIGHLIGHTS
- who: Hidekatsu Yanai and collaborators from the Department of Diabetes, Endocrinology and Metabolism, National Center for Global Health and Medicine Kohnodai Hospital, Kohnodai, Chiba, Japan have published the research work: Atherogenic Lipoproteins for the Statin Residual Cardiovascular Disease Risk, in the Journal: (JOURNAL)
- what: The study shows that elevated triglyceride (TG) levels reduced high-density lipoprotein cholesterol (HDL-C) and the existence of obesity/insulin resistance and diabetes may be important metabolic factors that determine CVD risk. One of the studies showed that, among eight RCTs that investigated the effect of statins vs. a placebo . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.